Context-Aware Graph Neural Networks (CAGNN) for Multimodal Prediction of Parkinson’s Disease Dementia

Parkinson’s disease dementia is a severe cognitive decline in up to 95% of Parkinson’s disease sufferers within 10–20 years after diagnosis. Diagnosis relies on comprehensive clinical evaluation; however, research indicates that underlying physiological changes to white matter tracts precede symptomatic presentation. Existing work has focused on symptomatic data or single imaging modalities, without exploiting 3D structural information available through fiber tractography. To the best of our knowledge, no existing framework effectively combines 3D fiber tractography and clinical population graphs for early PDD classification. A modular, context-aware geometric deep learning framework is developed to classify subjects into cognitive stages from baseline data, enabling future prediction. The method combines two graph neural network modules, processing white matter tractography as point-based graphs and inter-subject similarity using 16 clinical and cognitive features. Each module generates prediction probabilities, which are combined through a lightweight ensemble classifier to produce a final diagnostic label. Results demonstrate individual component elements outperform baseline models by approximately 10%, achieving accuracies between 75% and 82%. Similarly, a combined framework of both modules with an ensemble strategy further improves accuracy to 88%, exceeding individual module performance by over 10%, underscoring the importance of combining structural and contextual information for classification of cognitive states in Parkinson’s disease.

Authors

Institutions

Publication Details

Journal
Applied Artificial Intelligence
Published
2026-09-30
DOI
https://doi.org/10.1080/08839514.2026.2736303
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Context-Aware Graph Neural Networks (CAGNN) for Multimodal Prediction of Parkinson’s Disease Dementia

Huaizhong Zhang, Callum Altham, Ella Pereira
Applied Artificial Intelligence
Parkinson's Disease Mechanisms and Treatments
article

Context-Aware Graph Neural Networks (CAGNN) for Multimodal Prediction of Parkinson’s Disease Dementia

Huaizhong Zhang, Callum Altham, Ella Pereira
article en

Abstract

Parkinson’s disease dementia is a severe cognitive decline in up to 95% of Parkinson’s disease sufferers within 10–20 years after diagnosis. Diagnosis relies on comprehensive clinical evaluation; however, research indicates that underlying physiological changes to white matter tracts precede symptomatic presentation. Existing work has focused on symptomatic data or single imaging modalities, without exploiting 3D structural information available through fiber tractography. To the best of our knowledge, no existing framework effectively combines 3D fiber tractography and clinical population graphs for early PDD classification. A modular, context-aware geometric deep learning framework is developed to classify subjects into cognitive stages from baseline data, enabling future prediction. The method combines two graph neural network modules, processing white matter tractography as point-based graphs and inter-subject similarity using 16 clinical and cognitive features. Each module generates prediction probabilities, which are combined through a lightweight ensemble classifier to produce a final diagnostic label. Results demonstrate individual component elements outperform baseline models by approximately 10%, achieving accuracies between 75% and 82%. Similarly, a combined framework of both modules with an ensemble strategy further improves accuracy to 88%, exceeding individual module performance by over 10%, underscoring the importance of combining structural and contextual information for classification of cognitive states in Parkinson’s disease.

Applied Artificial IntelligenceVol. 40(1)
Edge Hill University (GB)
Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Biogen, Teva Pharmaceutical Industries, Celgene, Jazz Pharmaceuticals, Neurocrine Biosciences, Verily Life Sciences, Servier, H. Lundbeck A/S, Sun Pharma, Genentech, Allergan, Avid Radiopharmaceuticals
Openalex Percentile: Top 18%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.